Gene expression data of trial drug Dehydroabietylamine derivative-2 (DAAD-2) for Sensitive (HEP3B) and resistant (SNU449) hepatocellular carcinoma (HCC) cell lines with controls
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE88812
下载链接
链接失效反馈官方服务：
资源简介：
Hepatocellular carcinoma (HCC) is a highly prevalent and deadly disease world-wide. The survival of HCC patients is usually very poor due to the lack of efficient anti-cancer drugs acting against HCC cells. Structural modification is one of the important routes in chemical field for finding novel drugs with more potential bioactivities and broad bioactive spectra. Hence, a dehydroabietylamine derivative (DAAD-2) is prepared and subjected for cytotoxic activities on HCC cell lines. Qualitative, analytical study for gene expression profiling by array
创建时间：
2019-03-25
